NetTargets Inc.
24 Nov 2020
NetTargets participated at Bluepoint demo day 2020 on Nov 24 and our CEO, Minsoo Choi presented about our technologies.
In this 7th Bluepoint demo day, 12 inovative startups showed how they are solving problems from traditional industries with their new technologies. This event broadcasted live on Youtube.
See the link below for more details in Korean.
NetTargets will contribute its proprietary AI-based systems biology modeling technology to WOOJUNGBIO’s Open Innovation Project. By enabling quantitative simulation of biological responses and prediction of drug mechanisms, we are helping to shape a next-generation bioevaluation platform in the era of AI transformation.
NetTargets has been selected as one of the top 10 semifinalists among hundreds of drug discovery startups worldwide. The AI Discovery Award is an annual recognition by Nebius AI, a European AI-centric public cloud provider with global reach.
